GLP1R and hepatocellular carcinoma: Meanwhile, several retrospective cohort studies have compared the incidence of clinical outcomes, such as cirrhosis complications or HCC, in patients with type 2 diabetes who started treatment with GLP-1 RA versus those under other hypoglycemic therapies.